secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-209709
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q1 revenue up 21% to $403.5M; net income $14.2M; raises FY guidance
------------------------------------------------------------------------------

- Revenue $403.5M (+21% YoY); net income $14.2M vs $0.7M; Adjusted EBITDA $51.1M (+48%).
- Clinician base up 11% to 8,349 (net +309); visit volumes up 18% to 2.5M.
- Center Margin $135.9M (33.7% of revenue) vs $109.8M (33.0%).
- FY2026 guidance raised: revenue $1.64B-1.68B, Adj EBITDA $200M-220M; Q2 rev $405M-425M.
- Free cash flow $22.3M; cash $194.8M; net debt $262.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/0001193125-26-209709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/lfst-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-209709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer